Luteolin’s antiproliferative activity resides in the potential to induce cell cycle arrest via inhibiting IGF-1-mediated PI3K/PKB activation (Tuorkey, 2016), and ferulic acid has been proven effective in inhibiting proliferation of osteosarcoma cells (Zhang et al., 2016). Here, AKT1 is linked to osteosarcoma.